Stool-based surveillance for individuals with post-polypectomy indications has been shown to safely decrease the need for colonoscopies by 15% to 41%. A study of 3,453 participants found that multitarget stool DNA tests were most effective (AUC 0.72), but also more costly than colonoscopy. In contrast, fecal immunochemical tests were cost-saving. Overall, these strategies could revolutionize […]
Category: Surgical Endoscopy
Preoperative CT features predict surgical outcomes in gastric tumors
Enhanced lesion size on contrast CT significantly correlates with increased operative duration, extended hospital stays, and higher postoperative antibiotic use. A critical finding highlights the intraoperative perforation rate being markedly higher for tumors exhibiting outgrowth compared to those confined to the lumen (96.88% vs 29.11%, p < 0.001). The study underscores CT's superior accuracy in […]
Trans-cystic stenting reduces hospital stay and improves ERCP efficiency
Implementing trans-cystic biliary stenting during acute cholecystectomy significantly reduced the median total hospital stay from six to five days for patients needing both endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy. The stenting process was efficient, with 22 out of 23 attempts successful and a median insertion time of 14 minutes. Post-stenting, outpatient ERCP cases increased dramatically, […]
Endoscopic ultrasonography-guided ethanol injections demonstrate efficacy for small pancreatic tumors
A prospective multicenter study evaluated endoscopic ultrasonography-guided ethanol injections (EUS-EI) for treating small pancreatic neuroendocrine neoplasms (PNENs). Of the 25 patients treated, 76% achieved the primary endpoint compared to surgical outcomes, and 88% attained complete ablation at 1 and 6 months. Safety results were promising, with 96% experiencing no severe adverse events within one month. […]
Better IPMN risk stratification could optimize cancer surgery decisions.
Personalized Cancer Risk Thresholds Can Guide IPMN Surgery Decisions Clinicians found that optimal cancer risk thresholds (CRT) for surgery in patients with branch-duct intraductal papillary mucinous neoplasms (bd-IPMN) vary based on age, comorbidities, and tumor location. For a 60-year-old with mild comorbidities, surgery was favored at a 20% CRT for tumors in the pancreatic head […]
Small-sized capsule gastroscopy effectively screens gastrointestinal diseases
A retrospective analysis involving 2,163 asymptomatic individuals revealed that small-sized magnetically controlled capsule gastroscopy (mccg) successfully detected gastrointestinal issues such as submucosal tumors (1.57%), polyps (15.16%), and ulcers (1.25%). Detection rates for polyps were notably higher in females and increased with age. The procedure was well-tolerated, with no significant discomfort or adverse events reported, demonstrating […]
Prophylactic closure of mucosal defects lowers adverse event risks
Prophylactic closure of mucosal defects significantly reduces delayed bleeding and perforation risks following endoscopic resection, according to a systematic review and meta-analysis of 28 studies involving 11,383 patients. The closure group exhibited a 60% lower risk for delayed bleeding compared to non-closure (risk ratio: 0.40), although no significant reduction in postpolypectomy coagulation syndrome (PPCS) was […]
Double-balloon platform significantly reduces colorectal ESD procedure time
A randomized controlled trial demonstrated that the double-balloon interventional platform (DBIP) markedly reduced mean procedure time for colorectal endoscopic submucosal dissection (ESD) to 88.6 minutes, compared to 139.5 minutes for traditional ESD—a 36.5% reduction. Additionally, DBIP-assisted ESD improved en-bloc resection rates and sutured defect closures while saving $610.16 per patient, indicating its effectiveness and cost […]
Endoscopic submucosal dissection is pivotal for early gastric cancer treatment
Endoscopic submucosal dissection (ESD) is crucial for early gastric cancer (EGC) management, often necessitating additional gastrectomy in cases deemed non-curative. Analysis of 134 patients revealed key factors such as deep submucosal invasion and positive margins that led to further surgical intervention. Notably, independent risk factors for lymph node metastasis included positive vertical margin and lymphatic […]
Combination of hepaticogastrostomy and stenting enhances outcomes
A systematic review assessed the effectiveness of hepaticogastrostomy with antegrade stenting (hgas) compared to hepaticogastrostomy alone (hgs) for malignant biliary obstruction. Findings revealed pooled clinical success rates of 94% for hgas versus 88% for hgs, while re-intervention needs were significantly lower with hgas (OR=0.37). Although overall adverse events were similar, hgas led to reduced bile […]